Successful treatment of metastatic colorectal cancer with apatinib: report of two cases and literature review

Apatinib, a novel small molecule tyrosine kinase inhibitor that inhibits vascular endothelial growth factor receptor-2, was approved for metastatic gastric adenocarcinoma in China in Oct 2014. This is the first report on its use for advanced colorectal cancer as a kind of third-line therapy to date....

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Minghong, Yang, Jingru, Wang, Yaping, Zhang, Haoran, Gao, Zhenyuan, Zhou, Hairong, Shi, Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823067/
https://www.ncbi.nlm.nih.gov/pubmed/29497319
http://dx.doi.org/10.2147/OTT.S148412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5823067/
https://www.ncbi.nlm.nih.gov/pubmed/29497319
http://dx.doi.org/10.2147/OTT.S148412

Ejemplares similares